Just days after a federal court in Mississippi denied Novartis’ attempt to block the state’s 340B contract pharmacy access law, [...] …
Category: Contract Pharmacy Protection Bills
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this summer, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Beacon Hill lawmakers are expected to vote Thursday on a proposal that would prohibit pharmacy benefit managers (PBMs) from imposing [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
Missouri Become Eighth State to Enact 340B Contract Pharmacy Access Law After Governor Declines to Act on Bill
Missouri will become the eighth state to prohibit drug manufacturer 340B contract pharmacy restrictions after Gov. Mike Parson (R) announced [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
As hospital advocates prepared to begin their annual summer visits to Capitol Hill this week, five congressional Democrats signed on [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A group of Texas hospitals urged a federal court last week to grant their request for a summary judgement—or at [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drug manufacturers this week sued Kansas in an effort to block the state’s new contract pharmacy access law, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Delaware’s legislature passed a slimmed-down version of a 340B anti-discrimination bill in the eleventh hour of its legislative session Sunday, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...] …